EDGAR Filing Documents for 0001047469-19-001212

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-19-001212

Filing Date

2019-03-14

Accepted

2019-03-14 07:31:40

Documents

Period of Report

2018-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a2237988z10-k.htm	10-K	1266861
2	EX-23.1	a2237988zex-23_1.htm	EX-23.1	3484
3	EX-31.1	a2237988zex-31_1.htm	EX-31.1	7778
4	EX-31.2	a2237988zex-31_2.htm	EX-31.2	7789
5	EX-32.1	a2237988zex-32_1.htm	EX-32.1	4438
6	EX-32.2	a2237988zex-32_2.htm	EX-32.2	4481
	Complete submission text file	0001047469-19-001212.txt		6376560

Data Files

Seq	Description	Document	Type	Size
7	EX-101.INS	catb-20181231.xml	EX-101.INS	1491519
8	EX-101.SCH	catb-20181231.xsd	EX-101.SCH	47511
9	EX-101.CAL	catb-20181231_cal.xml	EX-101.CAL	51762
10	EX-101.LAB	catb-20181231_lab.xml	EX-101.LAB	458169
11	EX-101.PRE	catb-20181231_pre.xml	EX-101.PRE	334027
12	EX-101.DEF	catb-20181231_def.xml	EX-101.DEF	168612

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971

CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)